NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/26/2026
Back to search
Official data from USPTO
NUZYRA SUREPATH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NUZYRA SUREPATH
ST13
US500000097847647Class
16, 36, 44
Filing
97847647
Registration
8274500
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
05/26/2026
Trademark type
Word
Nice classes
16, 36, 44
Filing date
03/20/2023
Registration date
05/26/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/26/2026
Last transaction
05/26/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2023-05-00
First use in commerce
2023-05-00
Drawing code
4
Owner type
03
Owner location
Boston, MA, US
Examiner
BARREDA, AMBER KYLEE
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Paratek Pharmaceuticals, Inc.
Representatives
Keith Toms, Esq. MCCARTER & ENGLISH, LLP
Technical classification
Nice Classes
Class 16Class 36Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Printed medication dosage and formulation charts; printed informational cards and brochures in the field of infectious disease; printed informational cards and brochures in the field of pharmaceutical preparationsantibiotics
Class 36
Insurance consultancy services in the field of health; insurance servicesinsurance eligibility review and verification and consultation in the pharmaceutical industry; pharmaceutical benefit management services; insurance administration servicesassisting others with applying for insurance benefits
Class 44
Providing information in the field of pharmaceuticals for the treatment of infectious disease; medical information servicesproviding information to physicianshealthcare professionalspatients on the topic of pharmaceutical products in the field of infectious diseases; health care servicesproviding patient access programs to provide eligible patients with streamlined access to drugs in the field of infectious diseases; dispensing of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/26/2026
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/20/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/06/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/06/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/02/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/23/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/20/2025
IUAF
USE AMENDMENT FILED
09/19/2025
EISU
TEAS STATEMENT OF USE RECEIVED
09/19/2025
EX3G
SOU EXTENSION 3 GRANTED
09/19/2025
EXT3
SOU EXTENSION 3 FILED
09/19/2025
EEXT
SOU TEAS EXTENSION RECEIVED
09/19/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/15/2025
EX2G
SOU EXTENSION 2 GRANTED
03/14/2025
EXT2
SOU EXTENSION 2 FILED
03/14/2025
EEXT
SOU TEAS EXTENSION RECEIVED
03/14/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/10/2024
EX1G
SOU EXTENSION 1 GRANTED
09/10/2024
EXT1
SOU EXTENSION 1 FILED
09/10/2024
EEXT
SOU TEAS EXTENSION RECEIVED
09/10/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/19/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/23/2024
PUBO
PUBLISHED FOR OPPOSITION
01/23/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/18/2023
DOCK
ASSIGNED TO EXAMINER
12/14/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/11/2023
NWAP
NEW APPLICATION ENTERED
03/23/2023
Continuous trademark protection
Get notified about every new filing that threatens NUZYRA SUREPATH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.